New product: Sovaldi (sofosbuvir) 200 and 400 mg coated granules in sachet

This new formulation of Sovaldi is licensed for use in combination with other medicinal products for the treatment of chronic hepatitis C in adult and paediatric patients aged 3 years and above.

Source:

electronic Medicines compendium